Sector: Manufacturing Industry: Semiconductor and Related Device Manufacturing
52 week range:
1.54 - 15.04
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy.